Related by context. All words. (Click for frequent words.) 76 ocular adverse 74 treatment emergent adverse 74 severe hypoglycemic 72 hematological adverse 71 TEAEs 71 hematologic adverse 69 syncopal 69 events TEAEs 68 cerebrovascular adverse 67 Febrile neutropenia 67 discontinuations due 66 arterial thromboembolic 65 Disease ILD 65 neutropenia dehydration dyspnea 65 extrapyramidal symptoms 65 TYSABRI treated 65 thromboembolic 64 Erythropoietic therapies may 64 neuropsychiatric adverse 64 Adverse events 64 Serious ocular 64 headache nasopharyngitis 64 serious Interstitial Lung 64 laboratory abnormalities 63 Infusion Reactions Severe 63 ALT flares 63 apnea hypopnea 63 cardiovascular ischemic 63 cerebrovascular events 63 prolonged QT interval 63 Renal impairment 63 Thrombotic events 63 severe hypersensitivity reactions 63 arterial thromboembolic events 63 pyrexia mucositis sepsis febrile 63 acute coronary 63 ischemic cardiovascular 62 ischemic cerebrovascular 62 incidence ≥ 62 hallucinations dyskinesia 62 Hypotension 62 nonfatal cardiovascular 62 ipsilateral stroke 62 myocardial infarction stroke 62 VT VF 62 Peripheral edema 62 Serious adverse reactions 61 neutropenia thrombocytopenia 61 linaclotide treated 61 confirmed thrombotic cardiovascular 61 hypoglycemic events 61 events SAEs 61 macrovascular events 61 recurrent venous thromboembolism 61 VIIBRYD 61 EXJADE 61 recurrent VTE 61 receiving ISENTRESS 61 recurrent ischemic 61 hematologic toxicity 61 Severe acneform rash 61 recurrent coronary 61 hypoglycaemic episodes 61 somnolence sedation 61 lopinavir r arm 61 generalized edema 61 thromboembolic events 61 oral olanzapine 60 oxycodone CR 60 recurrent genital herpes 60 definite stent thrombosis 60 somnolence dizziness 60 ARCOXIA 60 Torsades de Pointes 60 discontinuations 60 PREZISTA r arm 60 ECG abnormalities 60 acute ischemic 60 cardiovascular thrombotic 60 nonfatal stroke 60 prednisone prednisolone 60 ARCALYST ® 60 Severe hypersensitivity reactions 60 experienced hypomagnesemia 60 reinfarction 60 intravitreal injections 60 nasopharyngitis headache 60 Discontinuations due 60 Treatment discontinuations due 60 recurrent ischemia 60 unstable angina pectoris 60 gastrointestinal perforation 60 Adverse reactions 60 salmeterol HFA MDI 60 CVD mortality 60 nonfatal MI 60 intracerebral hemorrhages 59 receiving XGEVA 59 anaphylactoid reactions 59 Cathy.Hales @ htimes.com 59 Hypocalcemia 59 Serious AEs 59 diarrhea nausea fatigue 59 cerebrovascular accidents 59 hypomagnesemia 59 acute gout flares 59 gout flare 59 dysglycemia 59 telaprevir dosing 59 PGTC seizures 59 unresectable HCC 59 events AEs 59 Anaphylactic reactions 59 simvastatin ezetimibe 59 gout flares 59 myocardial infarctions 59 periprocedural 59 asthma exacerbation 59 cytopenias 59 anemia neutropenia 59 desvenlafaxine succinate 59 intra abdominal abscess 59 COPD exacerbation 59 APTIVUS r 59 Discontinuations 59 ventricular tachycardia VT 59 ventricular tachyarrhythmia 59 severe exacerbations 59 symptomatic hypoglycemia 59 Postoperative complications 59 hepatic adverse 59 severe neutropenia 59 peripheral edema 58 alpha interferons 58 MEVACOR 58 leucopenia 58 RLAI 58 lipid lowering agents 58 paroxetine Paxil 58 VaD 58 headache abdominal pain 58 Serious Adverse Events 58 MADRS score 58 events MACE 58 NOLVADEX 58 EFFEXOR XR 58 torsades de pointes 58 RAPTIVA 58 Hepatotoxicity 58 Lactic acidosis 58 venous thromboembolic 58 bipolar mania trials 58 atherosclerotic cardiovascular 58 Exacerbations 58 intravenous bisphosphonates 58 insulin detemir 58 patients receiving ERBITUX 58 nasopharyngitis 58 thrombotic events 58 acute coronary syndromes ACS 58 serum phosphorous 58 symptomatic BPH 58 fulminant hepatitis 58 CIMZIA TM certolizumab pegol 58 arterial thrombotic 58 Acneform rash occurred 57 Auxilium anticipates 57 Hypersensitivity reactions 57 TMP SMX 57 venous thromboembolic events 57 Aranesp Therapy 57 recurrent glioblastoma multiforme 57 composite endpoint 57 del 5q MDS 57 receiving VELCADE 57 affective psychosis 57 HbA 1c levels 57 metformin accumulation 57 torsade de pointes 57 CHD CVD 57 ventricular arrhythmia 57 PASI scores 57 treatment emergent AEs 57 stent thromboses 57 ABC/3TC 57 divalproex 57 lumiracoxib 57 myocardial infarction ventricular fibrillation 57 mcg kg REBETOL 57 hepatic dysfunction 57 FluCAM arm 57 NNT = 57 AA Amyloidosis 57 neuropsychiatric symptoms 57 SAEs 57 symptomatic VTE 57 Kaplan Meier estimates 57 peripheral sensory neuropathy 57 NATRECOR R 57 nadroparin 57 Symptom onset 57 Heavy menstrual bleeding 57 vWD 57 constipation nausea 57 ARIXTRA 57 coinfected patients 57 HCV RESPOND 2 57 HIV HCV coinfected 57 TDF FTC 57 candidemia 57 dysmenorrhoea 57 HF hospitalization 57 adjunctive placebo 57 SSRI SNRI 57 venlafaxine Effexor 57 hypercalcemia 57 RLS symptoms 57 achieved ACR# 57 nadolol 57 efalizumab 57 β blockers 57 hypoglycemic episodes 57 neutropaenia 57 tolvaptan 57 NPH insulin 57 dapagliflozin plus 56 gastrointestinal bleeds 56 rFVIIa 56 GSK# [001] 56 octreotide LAR 56 elevated ALT 56 renal toxicity 56 ischemic strokes 56 headache nausea diarrhea 56 leukopenia 56 mcg albinterferon alfa 2b 56 flutamide 56 nontraumatic 56 Thrombocytopenia 56 superficial edema 56 Tardive dyskinesia 56 delayed CINV 56 biologic DMARD 56 KIF6 carriers 56 thrombo embolic 56 colorectal adenoma 56 dizziness somnolence 56 DETROL LA 56 paresthesias 56 glycated hemoglobin levels 56 cerebrovascular accident 56 Angioedema 56 Lupuzor ™ 56 thromboembolic complications 56 PEGINTRON TM 56 AGGRASTAT ® tirofiban hydrochloride 56 corrected QT interval 56 hematological toxicity 56 lymphopenia 56 antiandrogen 56 postintervention 56 Stent thrombosis 56 cerebral ischemic 56 induce orthostatic hypotension 56 acneform rash 56 severe asthma exacerbations 56 elevated plasma concentrations 56 parkinsonian symptoms 56 deep venous thromboses 56 QTc prolongation 56 relapsed MM 56 timepoint 56 hepatic failure 56 retinal vein occlusion RVO 56 thrombocytopenic 56 thromboembolism 56 MACCE 56 renal flares 56 AGILECT R 56 beclomethasone dipropionate 56 Neutropenia 56 myelosuppression 56 liver transaminases 56 Toxicities 56 PRADAXA #mg 56 syncope fainting 56 myocardial infarction MI 56 postmarketing adverse 56 postoperative AF 56 thrombocytopenia neutropenia 56 oxygen desaturation 56 tumor lysis syndrome 56 Virologic failure 56 Chronic ITP 56 Ulcerative colitis 56 mcg QD 56 angina pectoris 56 oxcarbazepine 56 HBeAg seroconversion 56 diarrhea nausea vomiting 56 heparin induced thrombocytopenia 56 post herpetic neuralgia PHN 56 recurrent DVT 56 resuscitated cardiac arrest 55 virologic failure 55 INVEGA ® 55 ticlopidine 55 rheumatoid arthritis HUMIRA 55 CANCIDAS 55 febrile neutropenia 55 virologic breakthrough 55 solifenacin 55 necrotizing pancreatitis 55 cardiovascular cerebrovascular 55 hyperkalemia 55 fluoxetine Prozac 55 NEUPOGEN 55 haematologic 55 SREs 55 baseline HbA1c 55 Lipitor #mg 55 ATACAND 55 generalized tonic clonic seizures 55 dalteparin 55 PEG INTRON 55 tegaserod 55 KRAS mutations occur 55 annualized relapse 55 ventricular fibrillation VF 55 hemorrhagic strokes 55 acute myocardial infarction AMI 55 ICD shocks 55 ARB telmisartan 55 nonaspirin 55 dyspareunia 55 lenalidomide dexamethasone 55 IOP lowering 55 intracerebral haemorrhage 55 cholecystitis 55 mucocutaneous reactions 55 serum creatinine levels 55 incontinence episodes 55 coronary revascularization 55 certolizumab 55 Soriatane 55 endometrial hyperplasia 55 sertraline Zoloft 55 anaphylactoid 55 NATRECOR ® 55 MULTAQ 55 concomitant AEDs 55 nonhematologic adverse reactions 55 invasive aspergillosis 55 timepoints 55 antiplatelet medications 55 Hyponatremia 55 venlafaxine XR 55 URTI 55 serum urate 55 LOVENOX R 55 mcg BID 55 myopathy rhabdomyolysis 55 venlafaxine ER 55 PRADAXA 55 unknown etiology 55 systemic embolism 55 nociceptive pain 55 ribavirin therapy 55 pericardial effusion 55 conventional antipsychotics 55 hemorrhagic complications 55 nondiabetic patients 55 spontaneous preterm birth 55 #mg doses [002] 55 nonfatal myocardial infarction MI 55 milrinone 55 analgesic medications 55 fluoxetine paroxetine 55 QT prolongation 55 oral FTY# 55 retrograde ejaculation 55 sustained ventricular tachycardia 55 Venous thromboembolism 55 COZAAR 55 headache arthralgia 55 serotonergic drugs 55 nighttime awakenings 55 clinically meaningful reductions 55 refractory gout 55 serious cardiovascular thrombotic 55 Arrhythmias 55 subclinical hypothyroidism 55 extrapyramidal disorder 55 noncardiac 55 syncopal episode 55 fatal anaphylactic 55 Hemorrhagic strokes 55 antiretroviral naive 55 inhospital 55 Ileus 55 IBS C 55 PENTASA 55 Paxil paroxetine 55 bezafibrate 55 atherothrombotic events 55 generalized seizures 55 colorectal adenomas 55 endophthalmitis 55 Severe hypoglycemia 55 mg simvastatin 55 vasomotor symptoms 55 ximelagatran 55 urate lowering therapy 55 ictal 55 FOLPI regimen 55 oxymorphone ER 55 gastrointestinal toxicity 55 HAM D# scores 55 symptomatic hyponatremia 55 optic neuropathy 54 Acute pancreatitis 54 Rituxan infusion 54 Severe cutaneous 54 anthracycline taxane 54 oral antidiabetes drugs 54 non valvular atrial 54 p = NS 54 adult chronic ITP 54 neutropenia febrile neutropenia 54 Oral mucositis 54 RISPERDAL 54 paroxetine sertraline 54 hematological toxicities 54 myalgia arthralgia 54 tolterodine ER 54 moderately emetogenic 54 T1DM 54 COPD exacerbations 54 hepatotoxicity 54 headache diarrhea nausea 54 dermatologic reactions 54 MIRAPEX 54 IIIa inhibitor 54 jaw ONJ 54 severe hypoglycemia 54 intracranial hemorrhage ICH 54 hyperprolactinemia 54 Aloxi injection 54 thrombophlebitis 54 tolterodine 54 pathological fractures 54 salmeterol fluticasone 54 adjunctive ABILIFY 54 Peripheral neuropathy 54 Hematologic 54 onset atrial fibrillation 54 amenorrhea 54 hepatorenal syndrome 54 ‰ ¥ 54 variceal bleeding 54 underwent CABG 54 oral hypoglycemic agent 54 beta blocker therapy 54 hypokalemia 54 LYSTEDA 54 postoperative mortality 54 pyridostigmine 54 teriflunomide 54 lacosamide 54 pruritus itching 54 tamoxifen Nolvadex ® 54 ruboxistaurin 54 Keppra R 54 ibandronate 54 Pharmacokinetic parameters 54 confusional arousals 54 IXEMPRA 54 evaluable subjects 54 nausea dizziness vomiting 54 oral diclofenac 54 Crohn Disease Activity 54 Overactive bladder 54 nausea constipation 54 PDE5 inhibitor 54 #mg/day [001] 54 benazepril 54 NYHA Class II 54 CYPHER R Sirolimus eluting 54 serum urate levels 54 FASLODEX 54 dizziness nausea diarrhea 54 paliperidone 54 MAOIs 54 aminotransferase elevations greater 54 methimazole 54 Diaries Diaries 54 tumor regressions 54 Opportunistic infections 54 postoperative nausea 54 HeFH 54 headache nausea fatigue 54 multivariate adjustment 54 ruptured aneurysms 54 elotuzumab 54 Primary endpoints 54 FIRMAGON 54 vulvovaginal atrophy 54 histologic subtype 54 diarrhea headache nausea 54 events thrombocytopenia neutropenia 54 â ‰ ¥ 54 psychiatric comorbidities 54 Eds Major 54 conjunctival hyperemia 54 atherogenic dyslipidemia 54 atherothrombotic disease 54 Telintra 54 Lamictal XR 54 proliferative diabetic retinopathy 54 lispro 54 anaphylactoid reaction 54 hyperphenylalaninemia HPA due 54 cerebrovascular 54 serum phosphate 54 ACTEMRA TM 54 symptomatic hypotension 54 IIIa inhibitors 54 prolactin levels 54 herpes zoster shingles 54 Pulmonary embolism 54 non selective NSAIDs 54 clazosentan 54 primary hypercholesterolemia 54 cardiac arrest supraventricular tachycardia 54 ug dose 54 rizatriptan 54 aldosterone antagonist 54 DU #b 54 stroke transient ischemic 54 prodromal symptoms 54 SPRYCEL ® 54 Sudden cardiac death 54 tardive dyskinesia TD 54 Tekamlo 54 tapentadol ER 54 proliferative retinopathy 54 serum aminotransferase levels 54 QTcF 54 silent ischemia 54 metformin sulfonylurea 54 sitaxsentan 54 symptomatic intracranial 54 Liver toxicity 54 intraocular inflammation 54 STRIDE PD 54 onset seizures 54 paclitaxel eluting stents 54 endoscopic remission 54 angiographic outcomes 54 Mucositis 54 exacerbations 54 neurologic dysfunction 54 beta blockers ACE inhibitors 54 ischemic complications 54 risperidone Risperdal 54 pancytopenia 54 Subarachnoid hemorrhage 54 acamprosate calcium 54 Known hypersensitivity 54 anaphylactic reactions bronchospasm 54 upper gastrointestinal bleeding 53 hematologic parameters 53 generalized anxiety disorder GAD 53 renal insufficiency 53 anterior uveitis 53 urolithiasis 53 QT interval prolongation 53 microbleeds 53 splenectomized patients 53 clinically meaningful improvements 53 varicella infection 53 diabetic gastroparesis 53 tipranavir r 53 SJIA 53 EDEMA4 trial 53 vaccinees 53 gouty arthritis 53 Severe allergic reactions 53 angioedema 53 DLTs 53 aldosterone antagonists 53 VFEND 53 Celebrex celecoxib 53 oral antidiabetic medication 53 nausea somnolence 53 COREG 53 acarbose 53 MCyR 53 antimuscarinic 53 haloperidol Haldol 53 ketoacidosis hyperosmolar coma 53 treats paroxysmal nocturnal 53 Androxal TM 53 HPA axis suppression 53 NIASPAN 53 LNG IUS 53 binary restenosis 53 Ramipril 53 Mg Uk 53 inhaled budesonide 53 VTEs 53 KETEK 53 quetiapine XR 53 gastrointestinal GI 53 torsemide ER 53 Natalizumab 53 ACTOplus met XR 53 oral prednisolone 53 hyperammonemia 53 idraparinux 53 orthostatic hypotension 53 angiographic restenosis 53 FOLPI 53 β blocker 53 Peripheral arterial disease 53 ziprasidone 53 PEGINTRON REBETOL combination 53 antiandrogens 53 aseptic meningitis 53 CIMZIA ™ 53 tapentadol IR 53 mania hypomania 53 cervicitis 53 moderate renal impairment 53 oral antidiabetic drugs 53 oral vancomycin 53 nausea diarrhea constipation 53 RISPERDAL ® 53 concomitant medications 53 apnea hypopnea index 53 Complication rates 53 cytopenia 53 quetiapine 53 BROVANA 53 Cimzia TM 53 thrombocytopenic patients 53 thrombocytopenia 53 conjugated equine estrogen 53 accompanying hypocalcemia 53 neutropenic fever 53 cardiac repolarization 53 lumbar spine BMD 53 variant angina 53 acute bipolar mania 53 H2 receptor antagonists 53 nonmelanoma skin cancers 53 nonfatal myocardial infarction 53 ischemic cardiomyopathy 53 preintervention 53 cabazitaxel 53 tibolone 53 noncardiovascular 53 ischemic cardiac 53 goserelin 53 parecoxib 53 nonsignificant 53 QT intervals 53 photosensitivity rash 53 vitamin B# folic acid 53 Dermatologic toxicities 53 symptom flare ups 53 renal impairment 53 TNF antagonist 53 macrovascular 53 LHRH agonists 53 EDSS scores 53 malignancy HCM 53 Progressive Multifocal Leukoencephalopathy PML 53 fosamprenavir 53 Myelosuppression 53 spinal cord compression 53 microbial keratitis 53 mg q8h 53 CRVO 53 osteoarthritis rheumatoid arthritis 53 PRISTIQ 53 nonvertebral fractures 53 #mg BID [003] 53 Enlarged prostate 53 decitabine 53 PSVT 53 neurologic complications 53 lipid lowering medication 53 manic hypomanic 53 antidepressants fluoxetine 53 primary generalized tonic 53 hypersensitivity reactions 53 pulmonary exacerbation 53 adrenal suppression 53 MACUGEN 53 mycophenolate mofetil 53 #mg/m# [001] 53 aspirin clopidogrel 53 pomalidomide 53 hyperacute 53 events ADEs 53 morphometric vertebral fractures 53 hypercholesterolemic patients 53 interferon gamma 1b 53 FROVA 53 FRAGMIN 53 rebleeding 53 intracranial bleeding 53 prolactin elevation 53 NSTEMI 53 abdominal pain abdominal discomfort 53 diarrhea vomiting nausea 53 optic neuropathy NAION 53 bone marrow suppression 53 akathisia 53 Severe infusion 53 peginterferon alfa 2b 53 Aortic stenosis 53 Major depressive disorder 53 hypocalcemia 53 acitretin 53 severe hypoglycaemia 53 ACEI ARB 53 hemorrhagic cystitis 53 ketoconazole 53 aortic insufficiency 53 accompanying electrolyte abnormalities 53 LATUDA 53 pseudoaneurysms 53 valvular disease 52 typical antipsychotics 52 hypersensitivity allergic reactions 52 overt nephropathy 52 estramustine 52 PREZISTA r 52 Urinary tract infections UTIs 52 lipid lowering medications 52 REBETOL combination therapy 52 INVEGA 52 posaconazole 52 uncertainties materialize Shire 52 primidone 52 + PH# 52 ADEs 52 nonmelanoma skin cancer 52 prospectively stratified 52 autonomic dysfunction 52 bypass graft CABG surgery 52 Antiepileptic drugs 52 Neuroleptic Malignant Syndrome NMS 52 Vertebral fractures 52 microvascular complications 52 tricyclic antidepressants 52 dysmenorrhea 52 preoperative radiotherapy 52 LAMICTAL 52 gemifloxacin 52 clozapine Clozaril 52 Avandia Actos 52 oxycodone IR 52 #.#mg/dL 52 tacrolimus ointment 52 serotonin reuptake inhibitors 52 INTEGRILIN 52 enalapril 52 Anal cancer 52 limiting toxicity 52 cerebral vasospasm 52 QTc interval 52 electrolyte disturbances 52 montelukast 52 coadministration 52 KENOSHA AREA CONVENTION 52 CRESTOR #mg 52 atorvastatin #mg 52 undergoing CABG 52 clonic seizures 52 acromegalic patients 52 chemotherapy induced neutropenia 52 tirofiban 52 nondepressed 52 ARCALYST 52 dose cohort 52 danazol 52 thyrotoxicosis 52 macroalbuminuria 52 atherothrombotic 52 ACUITY trial 52 advanced adenomas 52 divalproex sodium 52 AGILECT ® 52 A1c levels 52 valdecoxib 52 infarcts 52 Obstructive sleep apnea 52 DES implantation 52 thromboses 52 QTc 52 myoclonus 52 vasogenic edema 52 Restless Legs Syndrome RLS 52 pulmonary toxicity 52 hepatitis C genotype 52 VTE 52 Fibrillex TM 52 dopaminergic therapy 52 demyelinating 52 brivaracetam 52 REMINYL ® 52 angiotensin II receptor blockers 52 Ischemic 52 MYLOTARG 52 unprovoked seizures 52 neutrophil counts 52 atherosclerotic progression 52 pruritis 52 Vaprisol 52 BPH symptoms 52 carotid stenosis 52 Hypoglycemia 52 aplindore 52 serum calcium levels 52 hyperalgesia 52 postvaccination 52 lamotrigine 52 PLX STROKE targeting 52 placebo dexamethasone 52 unstable angina 52 ACR# responses 52 antiplatelet agent 52 relapsing remitting 52 Tasimelteon 52 INVEGA R 52 ADHF 52 azoospermia 52 AMEVIVE 52 haemorrhagic stroke 52 didanosine associated 52 ziconotide 52 monoclonal gammopathy 52 recurrent seizures 52 orchitis 52 bowel resection 52 ARIMIDEX 52 acute phosphate nephropathy 52 sUA 52 hypertension hypercholesterolemia 52 plus methotrexate 52 neutropenia anemia 52 mCRC acneform rash 52 ocular inflammation 52 invasive MRSA infections 52 atrial tachyarrhythmias 52 metabolic acidosis 52 RSD# oral 52 intracerebral hemorrhage 52 bacteriuria 52 balsalazide 52 inhaled anticholinergics 52 antithrombotics 52 anticholinergics 52 venlafaxine 52 nonvertebral fracture 52 CYPHER Stent 52 elevated creatinine 52 NIHSS score 52 transaminase elevations 52 Ischemic stroke 52 CYP#D# inhibitor 52 pioglitazone HCl 52 CIMZIA TM 52 leukotriene receptor antagonists 52 ventricular repolarization 52 hyperglycaemia 52 QVA# 52 external genital lesions 52 AGGRASTAT R tirofiban hydrochloride 52 agranulocytosis 52 antiphospholipid syndrome 52 systemic corticosteroid 52 imipenem 52 pharmacokinetic interactions 52 neurologic symptoms 52 lactic acidosis 52 olanzapine quetiapine 52 Arch Intern Med 52 ADPKD 52 interstitial pneumonia 52 Excessive daytime sleepiness 52 Insulin PH# 52 pamidronate 52 neurologic sequelae 52 uncontrolled hypertension 52 FOSRENOL ® 52 anticoagulant warfarin 52 pantoprazole Protonix 52 glitazone class 52 fibrinolysis 52 debilitating complication 52 MARINOL R 52 DAS# CRP 52 anemia leukopenia 52 abacavir lamivudine 52 CHD mortality 52 DOXIL 52 pathologic fracture 52 hepatic enzyme 52 nephrotoxicity 52 Serious Adverse Event 52 hour bronchodilation 52 retinal vein occlusion 52 Subgroup analyzes 52 antidiabetic drug 52 perioperative mortality 52 discontinued Viread 52 cerebral microbleeds 52 arthralgia 52 stable angina 52 amenorrhoea 52 antiarrhythmic drug 52 nitrofurantoin 52 SUSTENNA TM 52 coronary revascularization procedures 52 cisplatin gemcitabine 52 Doxil ® 52 rabeprazole 52 dextromethorphan quinidine 52 Perforomist Inhalation Solution 52 norethindrone acetate 52 myocardial infarctions MIs 51 ACTOplus met 51 REVLIMID ® 51 cholinesterase inhibitor 51 QTc intervals 51 systolic BP 51 omecamtiv mecarbil 51 neonatal morbidity 51 corticosteroid therapy 51 serologically active patients 51 Thyroid nodules 51 rosuvastatin Crestor 51 intravenous diuretics 51 liver histology 51 susceptible isolates 51 OSAHS 51 angiotensin converting enzyme inhibitors 51 HMG CoA reductase inhibitors 51 Certolizumab 51 ULTRAM ER 51 infarctions 51 mycophenolate mofetil MMF 51 TOPAMAX ® 51 cilostazol 51 juvenile idiopathic arthritis 51 Syndrome RLS 51 asymptomatic carotid stenosis 51 ACOMPLIA R 51 HbA 1C 51 Effexor venlafaxine 51 thromboembolic disease 51 pH#N# 51 anticonvulsants 51 calcineurin inhibitor 51 TELINTRA 51 albumin excretion rate 51 abacavir Ziagen 51 angioneurotic edema 51 pulmonary exacerbations 51 TAXUS p value 51 Post herpetic neuralgia 51 serum phosphate levels 51 disease CDAD 51 MYCAMINE 51 CP CPPS 51 Dyspepsia Tachycardia Myalgia etc. 51 mmHg diastolic 51 Tasigna prolongs 51 Recurrences 51 KAPIDEX 51 neurologic outcomes 51 tranylcypromine 51 neuroleptic malignant syndrome 51 rosuvastatin #mg 51 opioid induced bowel dysfunction 51 mild renal impairment 51 urinary N telopeptide 51 chlamydial infection 51 Ischaemic stroke 51 placebo controlled trials 51 elevated LDL cholesterol 51 symptomatic carotid stenosis 51 ribavirin RBV 51 bosentan 51 testicular tumors